aTyr Pharma Inc (NASDAQ: LIFE) stock closed at $3.27 on 9/29/20 after a major decline of -10.7%. Moreover, trading volume in this decline was exceptionally high at 253% of normal. The stock has performed in line with the market over the last nine months and has declined -18.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, LIFE is expected to be a major Value Eraser.
aTyr Pharma has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. aTyr Pharma has a neutral Appreciation Score of 50 and a slightly positive Power Rating of 62, resulting in the Positive Value Trend Rating.
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.